Novo Nordisk Opens Weight Drug to Telehealth Novo Nordisk (NYSE:NVO) on Tuesday said it will offer its weight loss drug Wegovy through telehealth providers Hims & Hers Health (NYSE:HIM), Ro and LifeMD ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Shares of Hims & Hers Health skyrocketed to 40% in the premarket following the telehealth company’s partnership announcement ...

Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on its telehealth platform.

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy ® (semaglutide). The Company is working with Hims ...

Telehealth company Hims & Hers (HIMS) announced Tuesday that it will begin selling Novo Nordisk’s (NVO) blockbuster weight loss drug Wegovy.

The companies announced a long-term collaboration to make obesity treatments more affordable, they said on Tuesday.

Novo Nordisk announced Tuesday it will partner with telehealth providers Hims & Hers Health, Ro, and LifeMD to sell its blockbuster weight-loss drug Wegovy, aiming to widen access now that supply ...

Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

Hims & Hers stock surges after Novo Nordisk announces Wegovy will be offered through telehealth platforms as shortages ease ...

Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans.

Hims & Hers Health (HIMS) stock surges following a partnership with Novo Nordisk (NVO) to sell the Danish drugmaker's weight ...